Xueqing Yu
Biographic Data
| ID | 7751922 |
|---|---|
| NAME | Xueqing Yu |
| GIVEN NAMES | Xueqing |
| FAMILY NAME | Yu |
| SIGNATURE | YU X |
| AFFILIATIONS | First Affiliated Hospital of Henan University |
| ORCID | 0000-0001-8624-744X |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
The efficacy and safety of Yiqi Huoxue Huatan granule in the treatment of stable COPD with chronic respiratory failure
ClinicalTrials.gov Identifier: NCT04208581
Trends in parkinson’s disease mortality in China from 2004 to 2021
The mortality rate of PD among Chinese residents increased from 2004 to 2021. Male sex, urban residence and age > 85 years were risk factors for PD-related death and should be the primary focus for PD prevention
Prevalence of chronic kidney disease in China
Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease
Bu-Fei Yi-Shen granule combined with acupoint sticking therapy showed beneficial effects for patients with stable COPD in the measured parameters over the 4-month treatment period and 6 months follow-up, with no relevant between-group differences in adverse events
No prominent works on this page.
Prevalence of chronic kidney disease in China
Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease
Bu-Fei Yi-Shen granule combined with acupoint sticking therapy showed beneficial effects for patients with stable COPD in the measured parameters over the 4-month treatment period and 6 months follow-up, with no relevant between-group differences in adverse events
Trends in parkinson’s disease mortality in China from 2004 to 2021
The mortality rate of PD among Chinese residents increased from 2004 to 2021. Male sex, urban residence and age > 85 years were risk factors for PD-related death and should be the primary focus for PD prevention
The efficacy and safety of Yiqi Huoxue Huatan granule in the treatment of stable COPD with chronic respiratory failure
ClinicalTrials.gov Identifier: NCT04208581
Medicine (4 works) · Pathology (3 works) · Chronic Obstructive Pulmonary Disease (COPD) Research (2 works) · COPD (2 works) · Internal Medicine (2 works) · Placebo (2 works) · Randomized controlled trial (2 works) · Acupuncture Treatment Research Studies (1 work) · Acute Kidney Injury Research (1 work) · Albuminuria (1 work)